Lv11
66 积分 2026-07-03 加入
Novel TYK2 inhibitor D-2570 in moderate- to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trial
29分钟前
求助中
IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study
8天前
已完结
Systemic Pharmacological Treatments for Chronic Plaque Psoriasis
15天前
已完结
A review of current therapeutics for psoriasis: Systemic and topical use of non-biological drugs
15天前
已完结
POS0016 Characterization of ORKA-002, a Novel Extended Half-life Monoclonal Antibody Targeting IL-17A/F for the Treatment of Psoriasis and Psoriatic Arthritis
21天前
已完结
Hidradenitis suppurativa
21天前
已完结
Systemic Pharmacological Treatments for Chronic Plaque Psoriasis
1个月前
已完结
Expanding the Global Perspective on Psoriasis
1个月前
已完结
Global Psoriasis Burden and Forecasts to 2050
1个月前
已完结
Epidemiological Analysis of Psoriasis in China from 2020 to 2022
1个月前
已完结
皖公网安备34019202002308
